About The Center
Audio and Video
Overview of Sleep Apnea Surgery
  Overview of adult sleep apnea surgery
  Overview of pediatric sleep apnea surgery
Patient Experiences
Surgical Solutions For Adults
Surgical Solutions For Children
Research Publications
FAQ
Contact Us
Home
 


OVERVIEW OF PEDIATRIC SLEEP APNEA SURGERY

Kasey K. Li, MD, DDS, FACS

INTRODUCTION 

Obstructive sleep apnea was first described in children in 1976 by Guilleminault.1 The prevalence of pediatric obstructive sleep apnea has been estimated to be between 1% to 3% in preschool and school-aged children. 2 More recently, the estimated pediatric obstructive sleep apnea prevalence has increased due to better monitoring techniques during polysomnography (PSG). 3 However, definitive data are still lacking. Although medical treatment such as nasal continuous positive airway pressure (CPAP) can be successful in treating pediatric obstructive sleep apnea and nasal steroid sprays can be effective in reducing the severity of OSA in children with allergic rhinitis, 4-7 most investigators would agree that these approaches are not the ideal long-term treatment for pediatric obstructive sleep apnea. Today, surgery remains as the first-line treatment, and adenotonsillectomy (T&A) is the most commonly performed surgical procedure for the treatment of pediatric obstructive sleep apnea.

THE PEDIATRIC OSA AIRWAY

In order to understand how T&A can impact OSA in children, one must understand how the airway is affected in pediatric obstructive sleep apnea. It has been demonstrated that the airway is smaller in children with obstructive sleep apnea compared to controls. 8,9 The adenoid and tonsils are larger and the airway is most restricted where adenoid and tonsils overlap. 8,9 In addition, a significant correlation between percent difference of the combined adenoid and tonsils volume and the apnea/hypopnea index (AHI) is found. 9 The adenoid and tonsils clearly play an important role in contributing to obstructive sleep apnea in children. Indeed, the disorder is most common between 2 to 6 years of age and correlates to the age of lymphoid hyperplasia during childhood. 10,11

WHY SHOULD WE TREAT PEDIATRIC SLEEP APNEA

It is clear that children with obstructive sleep apnea have associated morbidities. The cardiovascular risks due to obstructive sleep apnea are clearly demonstrated in adults with obstructive sleep apnea. Although there are less data on cardiovascular morbidities in children with obstructive sleep apnea, the existing evidence cannot be ignored. Children with obstructive sleep apnea have been shown to have an increased risk in developing systemic hypertension as well as right ventricular dysfunction due to elevated pulmonary arterial pressure. 12-15 Children with obstructive sleep apnea also have a higher risk of failure to thrive and impairment of growth development. Evidence suggests that growth hormone secretion is impaired, thus affecting growth. 16-18

The most extensive evidence on the impairment of obstructive sleep apnea in children is the neurocognitive and behavioral consequences. Although the hallmark of excessive daytime sleepiness seen in adults does not appear to be the major symptom in children, 19-21 behavior problems including hyperactivityinattention, aggression, sleepwalking and night terrors as well as impaired learning and diminished academic performance are the common symptoms. 22-28

ADENOTONSILLECTOMY

Historically, the most common indication for T&A was for infectious etiology. With the advances in antimicrobial therapy, we have witnessed a reduction in the frequency of this surgical procedure. Interestingly, an increase in airway compromise from adenotonsillar hypertrophy has been observed during the same period. 29 Today, obstructive sleep apnea is the most common indication for T&A. The rationale for the procedure as a treatment for OSA is simple. The removal of tissues in the airway lumen relieves obstruction and improves airway flow. Following T&A, the upper airway stability is improved due to reduction of collapsibility as measured by critical nasal pressure (Pcrit). 30

As stated earlier, T&A is the first line treatment for pediatric obstructive sleep apnea. Some surgeons perform only adenoidectomy in selected patients because of the concern with pain and suffering associated with post-operative recovery following tonsillectomy. It is important to emphasize that both tonsillectomy and adenoidectomy should be performed if the objective of the operation is to improve airway obstruction in obstructive sleep apnea. Although isolated adenoidectomy or tonsillectomy procedure does improve obstructive sleep apnea, the improvement may be insufficient, thus leading to further surgical procedures at a later date due to persistent symptoms. 31-35 In a review of 2,462 patients who underwent adenoidectomy during a five-year period, Kay and colleagues identified 108 patients who underwent subsequent tonsillectomy within 5.4 years of the adenoidectomy procedure. 34 The authors also found that the risk of subsequent tonsillectomy increased when the initial adenoidectomy was performed for upper airway obstruction.

ADENOTONSILLECTOMY OUTCOMES

There is a large body of evidence validating the improvement of obstructive sleep apnea after T&A. Methods that have been used in evaluating the outcomes of surgery include the comparison between pre- and post-operative symptomatology and school performance, as well as measurements such as PSG, echocardiogram, health-related quality-of-life surveys and neurocognitive testing. T&A results in significant improvement in the quality of life based on validated questionnaires measuring sleep disturbance, physical symptoms, emotional symptoms, hyperactivity and daytime functioning. 35-40 Pulmonary hypertension has normalized based on echocardiography assessment. 15, 41 School performance has improved23,27 and health care utilization has been reduced. 42 Abnormal PSG measurements including respiratory disturbance index, oxygen saturation and arousal index have also significantly resolved. 31,33,44 However, despite the documented success, many children continue to have residual OSA after surgery. In a review of 400 children who underwent surgical treatment of sleep-disordered breathing (SDB), Guilleminault and colleagues found persistent SDB in 58 (14.5%) of the children based on continual symptoms as well as PSG assessment. 31 This is consistent with the cumulative cure rate of 80% in a pool of 401 patients from 11 studies based on a recent review. 45 These findings may help explain the "learning debt" theory by Gozal and Pope, 25 in that they found children with lower academic performance are more likely to have snored during early childhood and require T&A for snoring compared with better-performing schoolmates. It is possible that these "treated" children may still have persistent SDB. Factors contributing to residual obstructive sleep apnea after T&A include severe OSA, obese children, positive family history of obstructive sleep apnea as well as African American children. 46-48 Untreated nasal obstruction and maxillofacial deformity that contribute to diminished airway dimension are also frequent findings in children inadequately treated with T&A. 49 Children with persistent obstructive sleep apnea may require further treatment including jaw expansion by orthodontics, nasal airway reconstruction or maxillofacial surgery to expand the upper airway. 49 Nasal CPAP may also need to be considered.

It also appears that the initial success of T&A diminishes with time. Guilleminault and colleagues were the first to report the recurrence of snoring and obstructive sleep apnea found in a group of pubertal and postpubertal teenagers who previously underwent T&A more than 10 years prior. 50 The authors suggested the presence of diminished airway dimension due to facial skeletal deficiency as contributing factors leading to recurrence. Similarly, Tasker and colleagues found that a group of subjects with previous evidence of obstructive sleep apnea prior to T&A continue to have evidence of narrower upper airways during sleep 12 years later. 51 The authors postulated that this may be one of the risk factors for later development of adult obstructive sleep apnea. A study on quality of life after T&A also found more pronounced improvement in the short term (seven months) than in the long term (nine to 24 months). 52

TONSILLECTOMY AND PARTIAL TONSILLECTOMY

Tonsillectomy is one of the most frequently undertaken surgical procedures. The traditional technique of "cold" dissection tonsillectomy with scissors, dissector and snares was introduced approximately 100 years ago. 53 The principle of tonsillectomy has been the removal of the entire tonsillar tissue. Due to concerns of recovery courses associated with pain and difficulty in swallowing, many techniques have been developed to lessen the post-operative suffering. In recent years, partial tonsillectomy (intracapsular tonsillectomy) with the use of power instruments, radiofrequency energy (coblation) or laser has been advocated because the procedure has been shown to result in less post-operative pain, earlier return to normal diet and daily activity. 54-56 The fundamental difference of partial tonsillectomy and the traditional tonsillectomy is that the capsule of the tonsil is not disturbed during removal. This is accomplished by leaving a portion of the tonsillar tissue next to the capsule undisturbed. Therefore, the underlying muscle is not encountered, thus reducing pain and the associated morbidity. Although there are numerous studies demonstrating that partial tonsillectomy improves obstructive symptoms based on non-validated questionnaires, 54-57 this procedure does leave more tonsillar tissues behind. 58,59 Thus it is not known if greater numbers of children have residual obstructive sleep apnea after surgery or if the recurrence of obstructive sleep apnea due to tonsil regrowth60 would be greater over time. Sorin and colleagues reported 3.2% of the 278 children who underwent partial tonsillectomy experienced tonsillar regrowth and recurrence of snoring just during a two-year period. 60 Furthermore, there are currently no objective data demonstrating that the improvement of obstructive sleep apnea is comparable to traditional tonsillectomy.

PUTTING IT ALL TOGETHER

There is convincing evidence that T&A improves obstructive sleep apnea in children. There is also convincing evidence that the treatment of obstructive sleep apnea may not end with T&A. Recent T&A technique focuses on the post-operative recovery course rather than the efficacy of the procedure as compared to the traditional technique. Additionally, we already know that even with the traditional technique of total tonsillectomy, residual obstructive sleep apnea persists and recurrence of OSA occurs in many children. Clearly, T&A should be offered as the first line treatment. However, the identification of children with significant nasal obstruction or maxillomandibular deficiency, which could increase risk of persistent obstructive sleep apnea after T&A, should be routine practice. Multidisciplinary treatment including skeletal expansion by orthodontic expansion to widen the airway, further surgical management such as jaw advancement in children with significant facial skeletal deficiency, as well as nasal CPAP therapy must be considered in continual management of children with persistent difficulty. 49 Parental counseling regarding the risk of recurrence and continual follow-up is essential in the management of pediatric obstructive sleep apnea.

REFERENCES

1.     Guilleminault C, Eldridge FL, Simmons FB, Dement WC.  Sleep apnea in eight children.  Pediatrics 1976;58:23-30.

2.     Ali NJ, Pitson DJ, Stradling JR.  Snoring, sleep disturbance, and behaviour in 4-5 year olds.  Arch Dis Child.  1993;68:360-366.

3.     Trang H, Leske V, Gaultier C.  Use of nasal cannula for detecting sleep apneas and hypopneas in infacts and children.  Am J Respir Crit Care Med 2002;166:464-468.

4.     Marcus CL, Ward SL, Mallory GB, et al.  J Pediatr.  Use of nasal continuous positive airway pressure as treatment of childhood obstructive sleep apnea.  1995;127:88-94.

5.     Waters KA, Everett FM, Bruderer JW, Sullivan CE.  Obstructive sleep apnea: the use of nasal CPAP in 80 children.  Am J Respir Crit Care Med.  1995;152:780-785.

6.     Mansfield LE, Diaz G, Posey Cr, Flores-Neder J.  Sleep disordered breathing and daytime quality of life in children with allergic rhinitis during treatment with intranasal budesonide.  Ann Allergy Asthma Immunol.  2004;92:240-244.

7.     Hughes K, Glass C, Ripechinski M, et al.  Effciacy of the topical nasal steroid budesonide on improving sleep and daytime somnolence in patients with perennial allergic rhinitis.  Allergy 2003;58:380-385.

8.     Arens R, McDonough JM, Corbin AM, et al.  Upper airway size analysis by magnetic resonance imaging of children with obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 2003;167:65-70.

9.     Arens R, McDonough JM, Tayag-Kier CE, et al.  MRI measurements of the upper airway structure in children with obstructive sleep apnea.  Am J Respir Crit Care Med 2001;164:698-703.

10.     Fujioka M, Young LW, Girdany BR.  Radiographic evaluation of adenoidal size in children: adenoidal-nasopharyngeal ratio.  AJR 1979;133:401-404.

11.     Jeans WD, Fernando DC, Maw AR, Leighton BC.  A longitudinal study of the growth of the nasopharynx and its contents in normal children.  Br J Radiol 1981;54:117-121.

12.     Marcus CL, Greene MG, Carroll JL.  Blood pressure in children with obstructive sleep apnea.  Am J Respir Crit Care Med 1998;157:1098-1103.

13.     Sofer S, Weinhouse E, Tal A, et al.  Cor pulmonale due to adenoidal or tonsillar hypertrophy or both in children.  Non-invasive diagnosis and follow-up.  Chest 1988;93:119-122.

14.     Tal A, Leiberman A, Margulis G, Sofer S.  Ventricular dysfunction in children with obstructive sleep apnea: radionuclide assessment. Pediatr Pulmonal 1988;4:139-143.

15.     Gorur K, Doven O, Unal M, Akkus N, Ozcan C.  Pre-operative and post-operative cardiac and clinical findings of patients with adenotonsillar hypertrophy.  Int J Pediatr Otorhinolaryngol 200159:41-46.

16.     Nieminen P, Lopponen T, Tolonen U, et al.  Growth and biochemical markers of growth in children with snoring and obstructive sleep apnea.  Pediatrics 2002;109:e55.

17.     Bar A, Tarasiuk A, Segev Y, Phillip M, Tal A.  The effect of adenotonsillectomy on serum insulin-like growth factor-I and growth in children with obstructive sleep apnea syndrome.  J Pediatr 1999;135:76-80.

18.     Yilmaz MD, Hosal AS, Oguz H, Yordam N, Kaya S.  The effects of tonsillectomy and adenoidectomy on serum IGF-I and IGFBP3 levels in children.  Laryngoscope 2002;112:922-925.

19.     Gozal D, Wang M, Pope DW.  Objective sleepiness measures in pediatric obstructive sleep apnea.  Pediatrics 2001;108:693-697.

20.     Carroll JL, McColley SA, Marcus CL, Curtis S, Loughlin GM.  Inability of clinical history to distinguish primary snoring from obstructive sleep apnea syndrome in children.  Chest 1995;108:610-618.

21.     Stein MA, Mendelsohn J, Obermyer WH, Amromin J, Benca R.  Sleep and behavior problems in school-aged children.  Pediatrics 2001:107:e60.

22.     Guilleminault C, Korobkin R, Winkle R.  A review of 50 children with obstructive sleep apnea syndrome.  Lung 1981;159:275-287.

23.     Ali NJ, Pitson D, Stradling JR.  Sleep disordered breathing: effects of adenotonsillectomy on behaviour and psychological functioning.  Eur J Paediatr 1996;155:56-62.

24.     Chervin RD, Dillon JE, Bassetti C, Ganoczy DA, Pituch KJ.  Symptoms of sleep disorders, inattention and hyperactivity in children.  Sleep 1997;20:1185-1192.

25.     Gozal D, Pope Jr. DW.  Snoring during early childhood and academic performance at ages 13 to 14 years.  Pediatrics 2001;107:1394-1399.

26.     Chervin RD, Archbold KH.  Hyperactivity and polysomnographic findings in children evaluated for sleep-disordered breathing.  Sleep 2001;24:313-320.

27.     Gozal D.  Sleep-disordered breathing and school performance in children.  Pediatrics 1998;102:616-620.

28.     Guilleminault C, Palombini L, Pelayo R, Chervin RD.  Sleepwalking and night terrors in prepubertal children: what triggers them?  Pediatrics 2003;111:e17-e25.

29.     >Grundfast KM, Wittich DJ Jr.  Adenotonsillar hypertrophy and upper airway obstruction in evolutionary perspective.  Laryngoscope 1982;92:650-656.

30.     Marcus CL, McColley SA, Carroll JL, Loughlin GM, Smith PL, Schwartz AR.  Upper airway collapsibility in children with obstructive sleep apnea syndrome.  J Appl Physiol 1994;77:918-924.

31.     Guilleminault C, Li KK, Khramtsov A, Pelayo R, Martinez S.  Sleep disordered breathing: surgical outcome in prepubertal children.  Laryngoscope 2004;114:132-137.

32.     Guilleminault C, Li KK, Quo S, Inouye RN.  A prospective study on the surgical outcomes of children with sleep-disordered breathing.  Sleep 2004;27:95-100.

33.     Nieminen P, Tolonen U, Lopponen H.  Snoring and obstructive sleep apnea in children. A 6-month follow-up study.  Arch Otolaryngol Head Neck Surg 2000;126:481-486.

34.     Kay DJ, Bryson PC, Casselbrant M.  Rates and risk factors for subsequent tonsillectomy after prior adenoidectomy: a regression analysis.  Arch Otolaryngol Head Neck Surg 2005;131:252-255.

35.     de Serres LM, Derkay C, Sie K, et al.  Impact of adenotonsillectomy on quality of life on children with obstructive sleep disorders.  Arch Otolaryngol Head Neck Surg 2002;128:489-496.

36.     Flanary VA.  Long-term effect of adenotonsillectomy on quality of life in pediatric patients.  Laryngoscope 2003;113:1639-1644.

37.     Goldstein NA, Fatima M, Campbell TF, Rosenfeld RM.  Child behavior and quality of life before and after tonsillectomy and adenoidectomy.  Arch Otolaryngol Head Neck Surg 2002;128:770-775.

38.     Stewart MG, Glaze DG, Friedman EM, Smith EO, Bautista M.  Quality of life and sleep study findings after adenotonsillectomy in children with obstructive sleep apnea.  Arch Otolaryngol Head Neck Surg 2005;131:308-314.

39.     Mitchell RB, Kelly J, Call E, Yao N.  Quality of life after adenotonsillectomy for obstructive sleep apnea in children.  Arch Otolaryngol Head Neck Surg.  2004;130:190-194.

40.     Avior G, Fishman G, Leor A, Sivan Y, Kaysar N, Derowe A.  The effect of tonsillectomy and adenoidectomy on inattention and impulsivity as measured by the test of variables of attention (TOVA) in children with obstructive sleep apnea syndrome.  Otolaryngol Head Neck Surg 2004;131:367-371.

41.     Miman MC, Kirazli T, Ozyurek R.  Doppler echocardiography in adenotonsillar hypertrophy.  Int J Pediatr Otorhinolaryngol 2000;11:21-26.

42.     Tarasiuk A, Simon T, Tal A, Reuveni H.  Adenotonsillectomy in children with obstructive sleep apnea syndrome reduces health care utilization.  Pediatrics 2004;113:351-356.

43.     Tal A, Bar A, Leiberman A, Tarasiuk A.  Sleep characteristics following adenotonsillectomy in children with obstructive sleep apnea syndrome.  Chest 2003;124:948-953.

44.     Mitchell RB, Kelly J.  Outcome of adenotonsillectomy for obstructive sleep apnea in children under 3 years.  Otolaryngol Head Neck Surg 2005 132:681-684.

45.     Lipton AJ, Gozal D.  Treatment of obstructive sleep apnea in children: do we really know how?  Sleep Med Rev  2003;7:61-80.

46.     Morton S, Rosen C, Larkin E, Tishler P, Aylor J, Redline S.  Predictors of sleep-disordered breathing in children with a history of tonsillectomy and/or adenoidectomy.  Sleep 2001;24:823-829.

47.     Suen JS, Arnold JE, Brooks LJ.  Adenotonsillectomy for treatment of obstructive sleep apnea in children.  Arch Otolaryngol Head Neck Surg 1995;121:525-530

48.     Mitchell RB, Kelly J.  Outcome of adenotonsillectomy for severe obstructive sleep apnea in children.  Int J pediatr Otolaryngol 2004;68:1375-79.

49.     Guilleminsult C, Lee JH, Chan A.  Pediatric obstructive sleep apnea syndrome.  Arch Pediatr Adolesc Med 2005;159:775-785.

50.     Guilleminault C, Partinen M, Praud JP, Quera-Salva MA, Powell N, Riley R.  Morphometric facial changes and obstructive sleep apnea in adolescents.  J Pediatr 1989;114:997-999.

51.     Tasker C, Crosby JH, Stradling JR.  Evidence fore persistence of upper airway narrowing during sleep, 12 years after adenotonsillectomy.  Arch Dis Child 2002;86:34-37.

52.     Mitchell RB, Kelly J, Call E, Yao N.  Long-term changes in quality of life after surgery for pediatric obstructive sleep apnea.  Arch Otolaryngol Head Neck Surg 2004;130:409-412.

53.     Mathews J, Lancaster J, Sherman I, Sullivan GO.  Guillotine tonsillectomy: a glimpse into its history and current status in the United Kingtom.  J Laryngol Otol 2002;116:988-991.

54.     Koltai PJ, Solares CA, Koempel JA, et al.  Intracapsular tonsillar reduction (partial tonsillectomy): reviving a historical procedure for obstructive sleep disordered breathing in children.  Otolaryngol Head Neck Surg 2003;129:532-538.

55.     Stoker KE, Don DM, Kang DR, et al.  Pediatric total tonsillectomy using coblation compared to conventional electrosurgery: a prospective, controlled single-blinded study.  Otolaryngol Head Neck Surg 2004;130:666-675.

56.     Linder A, Markstrom A, Hultcrantz E.  Using the carbon dioxide laser for tonsillotomy in children.  Int J Pediatr Otorhinolaryngol 1999;50:31-36.

57.     Bent JP, April MM, Ward RF, et al.  Ambulatory powered intracapsular tonsillectomy and adenoidectomy in children younger than 3 years old.  Arch Otolaryngol Head Neck Surg 2004;130:1197-2000.

58.     Chan KH, Friedman NR, Allen GC, et al.  Randomized, controlled, multisite study of intracapsular tonsillectomy using low-temperature plasma excisioin.  Arch Otolaryngol Head Neck Surg 2004;130:1303-1307.

59.     Friedman M, LoSavio P, Ibrahim H, Ramakrishnan V.  Radiofrequency tonsil reduction: safety, morbidity, and efficacy.  Laryngoscope 2003;113:882-887.

60.     Sorin A, Bent JP, April MM, Ward RF.  Complication of microdebrider-assisted powered intracapsular tonsillectomy and adenoidectomy.  Laryngoscope 2004;114:297-300.





 

About the Center | Overview of Sleep Apnea Surgery | Patient Experiences | Surgical Solutions for Adults | Surgical Solutions for Children
Research Publications | FAQ | Contact Us | Privacy Policy | Home